Last update 11 Jul 2024
Cardior Pharmaceuticals GmbH

Cardior Pharmaceuticals GmbH

Startups
|
Subsidiary Company|
2016|
Germany
|
10-50
|

Overview

Basic Info

Introduction
Cardior Pharmaceuticals is a biotech company that specializes in creating therapies for heart disease using non-coding RNA. Their primary focus is on developing CDR-132X, an oligonucleotide-based inhibitor of a molecular master switch (microRNA) that controls pathological changes in the heart after stress or injury. As an academic spin-off, Cardior aims to address the leading cause of death in the western world.

Tags

Cardiovascular Diseases
Other Diseases
Oligonucleotide
Antisense oligonucleotides

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Oligonucleotide3
Antisense oligonucleotides1
Top 5 TargetCount
miR-132(microRNA 132)1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
Phase 2 Clinical
Other
2
Login to view more data

Current Projects

Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free